Study marks first improvement in adjuvant endocrine therapy for early breast cancer in 20 ...

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor ...

In premenopausal women with non-metastatic breast cancer, use of tamoxifen may nearly double the risk of endometrial cancer, researchers report.

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...

Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer-driving protein long considered impossible to target with drugs—a ...

Gynecological malignancies constitute a rather significant health burden, worldwide, with an incidence rate of approximately 30.4 per 100,000 population.